UNH — Stock Film
STOCK FILMSCENE 1/11UNH · $385
Stock Expert AI presents
UNH
UnitedHealth Group Incorporated
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
UnitedHealth Group Incorporated. A quick introduction.

On the stock market since 1984, it operates in the world of health and science. It has 390,000 employees. Now — the numbers.

on the stock market since 1984
390K employees
$387B market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $3 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 3%

This is an established company with proven profits.

WHERE DOES THE MONEY COME FROM?
94%Unitedhealthcare
Unitedhealthcare 94%Optumhealth 6%
94% of all revenue comes from a single line: Unitedhealthcare.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

THE SALES TREND
Sales are growing, year after year.

Average growth of 12% a year over the last 4 years. Every year shown ended in profit.

$288B
2021
$324B
2022
$372B
2023
$400B
2024
$448B
2025
INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
80
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
50
average

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
88
very strong

The price looks reasonable next to what the company earns.

GROWTH
45
weak

Clearly below the class average.

PRICE MOMENTUM
63
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Growth: Sales growth trails the sector average.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Few are betting against it10/10
WEAK SPOTS
Thin profit on each sale3/10
Costs eat into the margin4/10
WORTH WATCHING

Profit per Sale: The profit kept from each sale is thin.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 38% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 3 years, sales grew about 11% a year on average.

2
THE BRIGHT SIDE · 2/3
Executives are buying their own stock

Over the last 12 months, company executives reported 96 buys and 27 sells. Management buying with its own money is usually read as a good sign.

3
THE BRIGHT SIDE · 3/3
Analysts’ target sits above today’s price

The average analyst price target is $47423% above today’s price.

1
THE RISKS · 1/3
A rich price tag

The company’s market value is 32 times its annual profit. Even a small disappointment could hit the price hard.

2
THE RISKS · 2/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 45/100.

3
THE RISKS · 3/3
Thin profit on each sale

As the slice kept from each sale thins out, so does the profit. Council score: 3/10.

FINALE · THE GRADE
B
0 / 100 · MoonshotScore

On our five-subject report card, UNH sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: UNH is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film